SecBot SecBot
8-K ·Filed Apr 14, 2026

LMAT

LEMAITRE VASCULAR INC
NEUTRAL
Impact 3/10
Horizonweeks Processed7mo ago SEC0001193125-26-153779
8-K context-dependent: Items 5.02, 8.01
Actionable Insight • Neutral

Monitor the outcome of David B. Roberts' election at the 2026 Annual Meeting and assess any potential shifts in board dynamics, though no material governance concerns are indicated.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$117.39
T+0 close · Apr 14, 2026 · via day close
Latest settled
−12.77%
T+60 · $102.40
Vs SPY
−21.29%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 14 $117.39entry
  2. T+1 · 7mo ago −2.20%α −2.97% · $114.81
  3. T+5 · 7mo ago −4.68%α −6.07% · $111.90
  4. T+20 · 6mo ago −13.42%α −19.71% · $101.64
  5. T+60 · 4mo ago −12.77%α −21.29% · $102.40
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

LeMaitre Vascular announced director Bridget Ross will not stand for re-election at the 2026 Annual Meeting, and the board nominated David B. Roberts to fill the Class II seat. Concurrently, the company reduced its board size from eight to seven members effective upon Ross's departure. These changes are part of a board rebalancing effort with no indication of operational disagreements.

Key Facts

  • Director Bridget Ross notified the board on April 8, 2026, of her decision not to stand for re-election at the 2026 Annual Meeting.
  • David B. Roberts was nominated to stand for election as a Class II director, contingent on his conditional resignation as a Class I director.
  • The board size is being reduced from eight to seven members effective upon Ross's departure.
  • The company stated Ross's decision is not related to any disagreement with the company.

Financial Impact

No direct financial impact disclosed

board compositiongovernance structure

Risk Factors

  • Potential for minor governance disruption during transition
  • Uncertainty around Roberts' qualifications and future board balance

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-153779
Document: 0001193125-26-153779-index-headers.html0001193125-26-153779
Document: 0001193125-26-153779-index.html0001193125-26-153779
Document: 0001193125-26-153779.txt0001193125-26-153779

Track record

14 reports on LMAT

Performance horizon

3 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +15.08% at T+20 after the May 7, 2026 report. 3 of 5 went positive at some point.

Filters
  1. Nov 4, 202612d ago 8-K Bearish 6/10 Entry $83.49 to $77.65 Now $77.01 +7.76% ▲ +6.99% +10.29% vs SPY
  2. Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Entry $80.60 to $79.02 Now $77.01 −4.45% ▼ −1.96% −1.37% vs SPY
  3. Oct 15, 20264w ago 8-K Neutral 2/10 Entry $80.82 to $84.45 Now $77.01 −4.71% ▲ +4.49% +4.40% vs SPY
  4. Aug 27, 202611w ago Press Release Neutral 2/10 Entry $80.45 to $80.67 Now $77.01 −4.28% ▲ +0.27% +0.16% vs SPY
  5. Jul 14, 202617w ago Press Release Neutral 1/10 Entry $99.79 Now $77.01 −22.83% No price data
  6. May 7, 202627w ago Insider Cluster Bearish 4/10 Entry $107.91 to $98.17 Now $77.01 +28.63% ▲ +9.03% +10.53% vs SPY
  7. May 7, 202627w ago Insider Cluster Neutral 2/10 Entry $107.91 to $98.17 Now $77.01 −28.63% ▼ −9.03% −10.53% vs SPY
  8. May 7, 202627w ago Insider Cluster Neutral 3/10 Entry $107.91 to $98.17 Now $77.01 −28.63% ▼ −9.03% −10.53% vs SPY
  9. May 5, 202627w ago 8-K Bullish 7/10 Entry $110.22 to $97.22 Now $77.01 −30.13% ▼ −11.79% −12.93% vs SPY
  10. Apr 14, 202630w ago DEFA14A Neutral 3/10 Entry $117.39 to $111.90 Now $77.01 −34.40% ▼ −4.68% −6.07% vs SPY
Showing 10 of 14

US Market Status

Market Closed · Opens in 6h 29m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 14, 2026